Correlation Between Embecta Corp and Heart Test

Can any of the company-specific risk be diversified away by investing in both Embecta Corp and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Embecta Corp and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Embecta Corp and Heart Test Laboratories, you can compare the effects of market volatilities on Embecta Corp and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Embecta Corp with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of Embecta Corp and Heart Test.

Diversification Opportunities for Embecta Corp and Heart Test

-0.27

Correlation Coefficient

Embecta Corp  Heart Test

Very good diversification

The 3 months correlation between Embecta and Heart is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Embecta Corp and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and Embecta Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Embecta Corp are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of Embecta Corp i.e., Embecta Corp and Heart Test go up and down completely randomly.

Pair Corralation between Embecta Corp and Heart Test

Given the investment horizon of 90 days Embecta Corp is expected to under-perform the Heart Test. But the stock apears to be less risky and, when comparing its historical volatility, Embecta Corp is 1.9 times less risky than Heart Test. The stock trades about -0.06 of its potential returns per unit of risk. The Heart Test Laboratories is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  360.00  in Heart Test Laboratories on May 2, 2025 and sell it today you would lose (48.00) from holding Heart Test Laboratories or give up 13.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Embecta Corp  vs.  Heart Test Laboratories

Embecta Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Embecta Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain rather sound which may send shares a bit higher in August 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Heart Test Laboratories

Risk-Adjusted Performance

Very Weak

Over the last 90 days Heart Test Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Heart Test is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Embecta Corp and Heart Test

The main advantage of trading using opposite Embecta Corp and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Embecta Corp position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.

The idea behind Embecta Corp and Heart Test Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.